Trading Report: The IMS Health Holdings Inc. (NYSE:IMS) Receives $31.00 Consensus Price Target from Analysts

The IMS Health Holdings Inc. (NYSE:IMS) Receives $31.00 Consensus Price Target from Analysts

Shares of IMS Health Holdings Inc. (NYSE:IMS) have been given a consensus recommendation of “Buy” by the ten analysts that are currently covering the stock. Three investment analysts have rated the stock with a hold rating and six have issued a buy rating on the company. The average 12 month price objective among brokerages that have covered the stock in the last year is $31.00.

Several equities analysts have weighed in on IMS shares. Zacks Investment Research upgraded shares of IMS Health Holdings from a “hold” rating to a “buy” rating and set a $34.00 target price for the company in a report on Wednesday, September 28th. TheStreet downgraded shares of IMS Health Holdings from a “buy” rating to a “hold” rating in a report on Monday, August 29th.

Several large investors have recently modified their holdings of the company. Artemis Investment Management LLP purchased a new stake in shares of IMS Health Holdings during the second quarter worth approximately $17,952,000. State Street Corp increased its stake in IMS Health Holdings by 10.6% in the first quarter. State Street Corp now owns 2,510,299 shares of the company’s stock worth $66,649,000 after buying an additional 241,422 shares during the last quarter. JPMorgan Chase & Co. increased its stake in IMS Health Holdings by 331.5% in the first quarter. JPMorgan Chase & Co. now owns 204,363 shares of the company’s stock worth $5,427,000 after buying an additional 157,000 shares during the last quarter. HBK Investments L P increased its stake in IMS Health Holdings by 36.5% in the first quarter. HBK Investments L P now owns 26,206 shares of the company’s stock worth $696,000 after buying an additional 7,006 shares during the last quarter. Finally, Pictet Asset Management Ltd. increased its stake in IMS Health Holdings by 1.4% in the first quarter. Pictet Asset Management Ltd. now owns 57,700 shares of the company’s stock worth $1,488,000 after buying an additional 800 shares during the last quarter. Institutional investors and hedge funds own 90.25% of the company’s stock.

IMS Health Holdings (NYSE:IMS) opened at 31.34 on Monday. The stock has a 50 day moving average of $30.07 and a 200 day moving average of $27.50. IMS Health Holdings has a one year low of $22.36 and a one year high of $31.59. The firm has a market capitalization of $10.32 billion, a price-to-earnings ratio of 76.07 and a beta of 0.83.

IMS Health Holdings (NYSE:IMS) last posted its earnings results on Wednesday, July 27th. The company reported $0.41 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $0.38 by $0.03. IMS Health Holdings had a net margin of 4.45% and a return on equity of 30.61%. The firm earned $802 million during the quarter, compared to the consensus estimate of $796.93 million. During the same period last year, the firm posted $0.37 EPS. The firm’s revenue for the quarter was up 112.4% on a year-over-year basis. Analysts forecast that IMS Health Holdings will post $1.62 earnings per share for the current year.

Related posts

Leave a Comment